Similarly, modulation of MAPK/ERK signaling in conjunction with CXCL10 expression patterns could help reduce inflammation-driven tumor progression or support T-cell infiltration, depending on the immunological profile of the tumor. The gene discussed is CXCL10; the disease is neoplasm.